FDA Adverse Event Injury Summary report: N

ASR UNI FEMORAL IMPL SIZE 55

MDR report key: 2871769 · Received December 13, 2012

Report

Report Number
1818910-2012-26964
Event Type
Injury
Date Received
December 13, 2012
Date of Event
December 4, 2012
Report Date
April 1, 2013
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z- 1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

**UPDATE** (B)(4) 2013 - PLAINTIFF¿S PRELIMINARY DISCLOSURE FORM WAS RECEIVED, WHICH IDENTIFIED DOB. THE COMPLAINT AND ASSOCIATED MDRS WERE UPDATED. THERE WAS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION.

Description of Event or Problem · 1

PATIENT WAS REVISED DUE TO CUP LOOSENING, PAIN, AND ELEVATED ION LEVELS. (LEFT HIP).

Description of Event or Problem · 1

LITIGATION PAPERS RECEIVED THAT ALLEGE THE PATIENT SUFFERED FROM PAIN, DIFFICULTY AMBULATING, MUSCLE LOSS, TISSUE DESTRUCTION AND ELEVATED METAL ION LEVELS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR UNI FEMORAL IMPL SIZE 55 FEMORAL HEAD KWA DEPUY INTERNATIONAL 2006203

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention